About this trial
This study will evaluate the impact of a novel non-pharmacological multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. This study design will also allow the investigators to evaluate a neural model supporting therapeutic alliance for pain outcomes for fibromyalgia.
Eligibility criteria
Qualifiers
Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
Ability to fully understand and consent to study procedures
Baseline pain intensity of at least 4/10
Disqualifiers
Any longer period of work experience involving pain treatment, pain rehabilitation etc.
Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
History of significant head injury
Trial design
Treatments tested in this trial
- Electroacupuncture
- Cognitive Training
- Education Training
Treatment groups
Sponsors and collaborators
Spaulding Rehabilitation Hospital
Lead sponsor
National Institutes of Health (NIH)
Collaborator